536 related articles for article (PubMed ID: 16043516)
1. A local mechanism mediates NAD-dependent protection of axon degeneration.
Wang J; Zhai Q; Chen Y; Lin E; Gu W; McBurney MW; He Z
J Cell Biol; 2005 Aug; 170(3):349-55. PubMed ID: 16043516
[TBL] [Abstract][Full Text] [Related]
2. NAD(+) and axon degeneration revisited: Nmnat1 cannot substitute for Wld(S) to delay Wallerian degeneration.
Conforti L; Fang G; Beirowski B; Wang MS; Sorci L; Asress S; Adalbert R; Silva A; Bridge K; Huang XP; Magni G; Glass JD; Coleman MP
Cell Death Differ; 2007 Jan; 14(1):116-27. PubMed ID: 16645633
[TBL] [Abstract][Full Text] [Related]
3. The Wlds transgene reduces axon loss in a Charcot-Marie-Tooth disease 1A rat model and nicotinamide delays post-traumatic axonal degeneration.
Meyer zu Horste G; Miesbach TA; Muller JI; Fledrich R; Stassart RM; Kieseier BC; Coleman MP; Sereda MW
Neurobiol Dis; 2011 Apr; 42(1):1-8. PubMed ID: 21168501
[TBL] [Abstract][Full Text] [Related]
4. Targeting NMNAT1 to axons and synapses transforms its neuroprotective potency in vivo.
Babetto E; Beirowski B; Janeckova L; Brown R; Gilley J; Thomson D; Ribchester RR; Coleman MP
J Neurosci; 2010 Oct; 30(40):13291-304. PubMed ID: 20926655
[TBL] [Abstract][Full Text] [Related]
5. Maintaining energy homeostasis is an essential component of Wld(S)-mediated axon protection.
Shen H; Hyrc KL; Goldberg MP
Neurobiol Dis; 2013 Nov; 59():69-79. PubMed ID: 23892229
[TBL] [Abstract][Full Text] [Related]
6. Axon degeneration: Mechanisms and implications of a distinct program from cell death.
Yan T; Feng Y; Zhai Q
Neurochem Int; 2010 Mar; 56(4):529-34. PubMed ID: 20117162
[TBL] [Abstract][Full Text] [Related]
7. Nicotinamide mononucleotide adenylyltransferase expression in mitochondrial matrix delays Wallerian degeneration.
Yahata N; Yuasa S; Araki T
J Neurosci; 2009 May; 29(19):6276-84. PubMed ID: 19439605
[TBL] [Abstract][Full Text] [Related]
8. Nmnat2 delays axon degeneration in superior cervical ganglia dependent on its NAD synthesis activity.
Yan T; Feng Y; Zheng J; Ge X; Zhang Y; Wu D; Zhao J; Zhai Q
Neurochem Int; 2010 Jan; 56(1):101-6. PubMed ID: 19778564
[TBL] [Abstract][Full Text] [Related]
9. Mislocalization of neuronal mitochondria reveals regulation of Wallerian degeneration and NMNAT/WLD(S)-mediated axon protection independent of axonal mitochondria.
Kitay BM; McCormack R; Wang Y; Tsoulfas P; Zhai RG
Hum Mol Genet; 2013 Apr; 22(8):1601-14. PubMed ID: 23314018
[TBL] [Abstract][Full Text] [Related]
10. Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene.
Mack TG; Reiner M; Beirowski B; Mi W; Emanuelli M; Wagner D; Thomson D; Gillingwater T; Court F; Conforti L; Fernando FS; Tarlton A; Andressen C; Addicks K; Magni G; Ribchester RR; Perry VH; Coleman MP
Nat Neurosci; 2001 Dec; 4(12):1199-206. PubMed ID: 11770485
[TBL] [Abstract][Full Text] [Related]
11. Reducing expression of NAD+ synthesizing enzyme NMNAT1 does not affect the rate of Wallerian degeneration.
Conforti L; Janeckova L; Wagner D; Mazzola F; Cialabrini L; Di Stefano M; Orsomando G; Magni G; Bendotti C; Smyth N; Coleman M
FEBS J; 2011 Aug; 278(15):2666-79. PubMed ID: 21615689
[TBL] [Abstract][Full Text] [Related]
12. Nicotinamide mononucleotide adenylyl transferase-mediated axonal protection requires enzymatic activity but not increased levels of neuronal nicotinamide adenine dinucleotide.
Sasaki Y; Vohra BP; Lund FE; Milbrandt J
J Neurosci; 2009 Apr; 29(17):5525-35. PubMed ID: 19403820
[TBL] [Abstract][Full Text] [Related]
13. NAD and axon degeneration: from the Wlds gene to neurochemistry.
Wang J; He Z
Cell Adh Migr; 2009; 3(1):77-87. PubMed ID: 19372760
[TBL] [Abstract][Full Text] [Related]
14. Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration.
Araki T; Sasaki Y; Milbrandt J
Science; 2004 Aug; 305(5686):1010-3. PubMed ID: 15310905
[TBL] [Abstract][Full Text] [Related]
15. Nicotinamide mononucleotide adenylyltransferase 1 gene NMNAT1 regulates neuronal dendrite and axon morphogenesis in vitro.
Zhao H; Zhang JY; Yang ZC; Liu M; Gang BZ; Zhao QJ
Chin Med J (Engl); 2011 Oct; 124(20):3373-7. PubMed ID: 22088538
[TBL] [Abstract][Full Text] [Related]
16. WldS but not Nmnat1 protects dopaminergic neurites from MPP+ neurotoxicity.
Antenor-Dorsey JA; O'Malley KL
Mol Neurodegener; 2012 Feb; 7():5. PubMed ID: 22315973
[TBL] [Abstract][Full Text] [Related]
17. NMNAT1 inhibits axon degeneration via blockade of SARM1-mediated NAD
Sasaki Y; Nakagawa T; Mao X; DiAntonio A; Milbrandt J
Elife; 2016 Oct; 5():. PubMed ID: 27735788
[TBL] [Abstract][Full Text] [Related]
18. Wld S requires Nmnat1 enzymatic activity and N16-VCP interactions to suppress Wallerian degeneration.
Avery MA; Sheehan AE; Kerr KS; Wang J; Freeman MR
J Cell Biol; 2009 Feb; 184(4):501-13. PubMed ID: 19237597
[TBL] [Abstract][Full Text] [Related]
19. An Atypical SCF-like Ubiquitin Ligase Complex Promotes Wallerian Degeneration through Regulation of Axonal Nmnat2.
Yamagishi Y; Tessier-Lavigne M
Cell Rep; 2016 Oct; 17(3):774-782. PubMed ID: 27732853
[TBL] [Abstract][Full Text] [Related]
20. Molecular chaperones protect against JNK- and Nmnat-regulated axon degeneration in Drosophila.
Rallis A; Lu B; Ng J
J Cell Sci; 2013 Feb; 126(Pt 3):838-49. PubMed ID: 23264732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
